A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Launched by PROGENABIOME · Jul 23, 2019
Trial Information
Current as of May 01, 2025
Unknown status
Keywords
ClinConnect Summary
The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
- • 2. Male or female patients of any age (interest is given to children to compare with mothers).
- Exclusion Criteria:
- • 1. Refusal to sign informed consent form
- • 2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
- • 3. Postoperative stoma, ostomy, or ileoanal pouch
- • 4. Participation in any experimental drug protocol within the past 12 weeks
- • 5. Treatment with total parenteral nutrition
- • 6. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
- • 7. Inability to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study
About Progenabiome
Progenabiome is a pioneering clinical trial sponsor dedicated to advancing the understanding and treatment of microbiome-related health conditions. By leveraging cutting-edge research and innovative methodologies, Progenabiome conducts rigorous clinical studies aimed at uncovering the complex interactions between the human microbiome and various diseases. Committed to scientific excellence and patient-centric approaches, the company collaborates with leading academic institutions and healthcare professionals to develop novel therapeutic strategies that enhance health outcomes and improve quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ventura, California, United States
Patients applied
Trial Officials
Sabine Hazan, MD
Study Director
ProgenaBiome
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials